Table: Aska Pharmaceutical Holdings - 6-MTH group results

ASKA Pharmaceutical Holdings

01/11/2021 06:00

Nov 1 (Reuters)- 
             Aska Pharmaceutical Holdings Co., Ltd. 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 6 months ended      6 months ended        Year to  
                Sep 30, 2021        Sep 30, 2020      Mar 31, 2022  
                   LATEST             YEAR-AGO           LATEST     
                   RESULTS             RESULTS          FORECAST    
  Sales             28.48                                 54.50     
  Operating          2.66                                  3.50     
  Recurring          2.74                                  3.60     
  Net             loss 2.80                             loss 2.60   
  EPS          loss 98.52 yen                        loss 91.62 yen 
  Ann Div                                               14.00 yen   
  -Q2 div         7.00 yen                                          
  -Q4 div                                               7.00 yen    
  
  NOTE - Aska Pharmaceutical Holdings Co., Ltd.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4886.T